Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.890
-0.090 (-4.55%)
At close: Sep 28, 2026, 4:00 PM EDT
1.900
+0.010 (0.53%)
Pre-market: Sep 29, 2026, 6:07 AM EDT
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $13.28 million as of September 28, 2026.
Market Cap
13.28M
Enterprise Value
4.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.89
ChartMarket Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $13.28M, a decrease of -66.34%. That is a compound annual growth rate of -73.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 13.28M | -61.97% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daxor | 64.28M |
| Precision Optics Corporation | 50.67M |
| Nephros | 45.94M |
| Milestone Scientific | 36.45M |
| Harvard Bioscience | 36.24M |
| Retractable Technologies | 20.95M |
| Femasys | 20.77M |
| Bionano Genomics | 19.55M |